大麻二酚通过抗炎、抗氧化和抗血管生成作用治疗实验性大鼠子宫内膜异位症的潜在新方法
在大鼠子宫内膜异位症模型中,5 mg/kg 大麻二酚(CBD)腹腔注射 7 天可缩小内膜异位病灶面积,降低血清和腹腔液中氧化应激与炎症指标,并在部分血管生成和炎症标志物上优于亮丙瑞林。
要点
- 5 mg/kg CBD 组病灶面积、血清 TOS、OSI、IL-6、TNF-α 及腹腔液 OSI、IL-6、TNF-α 均较生理盐水组显著降低。
- 5 mg/kg CBD 组血清和腹腔液 TAS 较生理盐水组显著升高。
- 5 mg/kg CBD 组与亮丙瑞林组在血清和腹腔液炎症及氧化应激参数上相似。
核心结论
- 由于具有抗炎、抗氧化和抗血管生成作用,CBD 可能成为子宫内膜异位症的治疗候选药物。
研究设计与样本
- 在 36 只雌性 Wistar 白化大鼠中手术诱导子宫内膜植入物,确认病灶后随机分为四组。
- 亮丙瑞林组单次皮下注射 1 mg/kg 亮丙瑞林;其余三组分别为 5 mg/kg CBD、生理盐水溶液和 20 mg/kg CBD,每日腹腔注射,持续 7 天。
- 21 天后处死大鼠,检测血液和腹腔液样本中的 TAS、TOS、OSI、IL-6 和 TNF-α,并对子宫内膜异位组织进行 TNF-α、IL-6 和 VEGF 免疫组化染色。
主要发现
- 与生理盐水组相比,5 mg/kg CBD 组子宫内膜异位植入物表面积(P = 0.0213)、血清 TOS(P = 0.0491)、OSI(P = 0.0056)、IL-6(P = 0.0236)、TNF-α(P = 0.0083)以及腹腔液 OSI(P = 0.0401)、IL-6(P = 0.0205)、TNF-α(P = 0.0045)浓度均显著降低。
- 与生理盐水组相比,5 mg/kg CBD 组血清 TAS(P = 0.0012)和腹腔液 TAS(P = 0.0145)浓度升高。
- 5 mg/kg CBD 组与亮丙瑞林组在血清和腹腔液样本的炎症及氧化应激参数上相似。
- 与亮丙瑞林组相比,5 mg/kg CBD 组表面上皮和基质细胞中 VEGF 的平均强度均显著降低(两者 P = 0.002),仅表面上皮细胞中 IL-6 显著降低(P = 0.0108)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can cannabidiol (CBD) be used in the treatment of endometriosis for its anti-inflammatory, antioxidative and antiangiogenic effects? DESIGN: Endometrial implants were surgically induced in 36 female Wistar albino rats. After confirmation of endometriotic foci, the rats were randomized into four groups. In the leuprolide acetate group, rats were given a single 1 mg/kg s.c. leuprolide acetate injection. The other groups were 5 mg/kg CBD (CBD5), saline solution and 20 mg/kg CBD (CBD20); daily i.p. injections were administered for 7 days. After 21 days, the rats were euthanised, and total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) measurements in blood and peritoneal fluid samples, and immunohistochemical staining for TNF-α, IL-6 and vascular endothelial growth factor (VEGF) of endometriotic tissues were evaluated. RESULTS: Significant reductions in the endometriotic implant surface area (P = 0.0213), serum TOS (P = 0.0491), OSI (P = 0.0056), IL-6 (P = 0.0236), TNF-α (P = 0.0083) and peritoneal fluid OSI (P = 0.0401), IL-6 (P = 0.0205) and TNF-α (P = 0.0045) concentrations were observed in the CBD5 group when compared with the saline solution group. Compared with the saline solution group, increased TAS concentrations in serum (P = 0.0012) and peritoneal fluid (P = 0.0145) were found in the CBD5 group. The CBD5 and leuprolide acetate groups were similar regarding inflammatory and oxidative stress parameters of serum and peritoneal fluid samples. The CBD5 group showed significantly lower mean intensity in both surface epithelium and stromal cells for VEGF (both P = 0.002) and only in surface epithelium cells for IL-6 (P = 0.0108), when compared with the leuprolide acetate group. CONCLUSION: Due to its anti-inflammatory, antioxidative and antiangiogenic effects, CBD might be a therapeutic agent candidate for endometriosis.
引用
- Okten SB, Cetin C, Tok OE, et al. Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model. Reprod Biomed Online. 2023. PMID: 36997400. doi:10.1016/j.rbmo.2023.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。